CARVYKTI 3.2 × 10^6 – 1 × 10^8 cells dispersion for infusion
*Company:
Janssen Sciences Ireland (a Johnson & Johnson Company)Status:
NewLegal Category:
Product subject to medical prescription which may not be renewed (A)Active Ingredient(s):
This medicinal product is subject to additional monitoring.
*Additional information is available within the SPC or upon request to the company
File name
DHPC_-_Secondary_Malignancy_-_HPRA_Final-Signed.docx.pdf
Reasons for updating
- Add New Doc
Updated on 02 April 2026
File name
EN_IE-CARVYKTI-PIL_20260130_IA_0000323641-clean-Approved.pdf
Reasons for updating
- New PIL for new product
Free text change information supplied by the pharmaceutical company
EMA/VR/0000272240 – Type II - Addition of Ghent-Techlane manufacturing site
Updated on 02 April 2026
File name
EN_IE-CARVYKTI-SmPC_20260130_IA_0000323641-clean-Approved.pdf
Reasons for updating
- New SPC for new product
Legal category:Product subject to medical prescription which may not be renewed (A)
Free text change information supplied by the pharmaceutical company
EMA/VR/0000294863 - Type IA - PRAC recommendation for progressive multifocal leukoencephalopathy
File name
CARVYKTI Patient Card EM-189878-March 2026.pdf
Reasons for updating
- Add New Doc
File name
CARVYKTI My CAR-T Journey Guide EM-189580-March 2026.pdf
Reasons for updating
- Add New Doc
File name
CARVYKTI Product Handling Guide EM-189877-March 2026.pdf
Reasons for updating
- Add New Doc
File name
CARVYKTI CAR-T Centre HCP Guide EM-189675-March 2026.pdf
Reasons for updating
- Add New Doc
Janssen Sciences Ireland (a Johnson & Johnson Company)
Address:
Janssen Sciences Ireland UC, Barnahely, Ringaskiddy, IRL - Co. Cork P43 FA46Medical Information E-mail:
medinfo@its.jnj.comTelephone:
+353 1 4665200Website:
https://innovativemedicine.jnj.com/ireland/Medical Information Direct Line:
1800 709 122